CD274 and head and neck squamous cell carcinoma: Recently, it has been reported that the levels of exosomal PD-L1 in the plasma, rather than soluble PD-L1, were associated with disease progression in patients with head and neck squamous cell carcinomas (HNSCCs) [49].